GFM Network News


Investors pile into Bayer bond to pay settlement charges

Reading Time: < 1 minute Amsterdam | Reuters — Investors piled into a Bayer bond on Wednesday that will help pay for a long-negotiated settlement of U.S. lawsuits claiming its widely-used herbicide Roundup caused cancer. Demand for the four-tranche bond sale, whose proceeds will include the litigation payments, exceeded 17.5 billion euros, nearly three times the six billion euros (C$9.15 […] Read more

U.S. settlements not expected to change availability, labels for glyphosate, dicamba

Bayer to pay up to US$12 billion to resolve ag chem, PCB claims; company is "not contemplating" a Canadian glyphosate settlement

Reading Time: 5 minutes Updated, June 25 — Farmers in Canada, the U.S. and elsewhere shouldn’t expect any changes to availability or label directions for Bayer’s stable of glyphosate and dicamba herbicides, coming out of a massive settlement for thousands of lawsuits, the company says. The German company announced Wednesday it expects to spend up to $12 billion in […] Read more


Bayer reportedly near glyphosate settlement after lengthy talks

Proposed settlement said to include $2 billion for future cases

Reading Time: 2 minutes Reuters — Germany’s Bayer is set to reach a settlement this week with U.S. plaintiffs that claim its glyphosate-based herbicides cause cancer, two people familiar with the matter told Reuters. After more than a year of talks, however, some details and the overall amount of the settlement have yet to be finalised, one of the […] Read more

U.S. court blocks California cancer label on Roundup

WHO agency's ruling alone insufficient, judge says

Reading Time: 2 minutes Reuters — A U.S. federal appeals court on Monday blocked California from requiring that Bayer label its glyphosate-based herbicide Roundup with a cancer warning, handing the company a victory in its ongoing litigation over the product. In his ruling, U.S. District Judge William Shubb called California’s cancer warning misleading and said the state’s label is […] Read more


Bayer scraps plans for U.S. dicamba production

Move unrelated to court ruling, company says

Reading Time: 2 minutes Chicago | Reuters — Bayer said on Tuesday it will scrap a nearly US$1 billion project to produce dicamba in the United States, but said the move is unrelated to a federal court decision that blocked sales of dicamba-based herbicides. The German-based company is moving to save cash as it wages an expensive legal battle […] Read more

Elanco gets EU’s conditional antitrust OK for Bayer deal

Approval calls for sale of Vecoxan brand, among others

Reading Time: < 1 minute Reuters/Staff — Elanco Animal Health secured antitrust clearance on Monday from the European Union to buy Bayer’s veterinary drugs unit, after pledging to sell some products to address competition concerns about the US$7.6 billion deal. The European Commission said the companies will sell either Elanco or Bayer’s products or those in the pipeline, including licenses, […] Read more


Court blocks sales of dicamba in U.S.

Bayer says it's seeking new EPA registration for 2021

Reading Time: 3 minutes Updated — Reuters — A U.S. appeals court has blocked Bayer from selling an agricultural weed killer in the United States, the latest setback for a business already fighting an expensive legal battle over another product. A three-judge panel of the Ninth U.S. Circuit Court of Appeals ruled the U.S. Environmental Protection Agency (EPA) substantially […] Read more

Bayer reporting progress in Roundup settlement talks

Reading Time: 2 minutes Frankfurt | Reuters — Bayer said on Monday it had made progress seeking a settlement over claims its glyphosate-based Roundup herbicide causes cancer, after Bloomberg reported the company reached a verbal agreement on about 50,000 to 85,000 cases. The drugs and pesticides group is keen to draw a line under the legal dispute, which it […] Read more


Proxy advisers split over endorsing Bayer management

Chemical giant to host AGM April 28

Reading Time: 2 minutes Frankfurt | Reuters — Shareholder advisory groups are divided over whether to endorse the management and directors at German drugs and pesticides company Bayer, according to recommendations submitted by proxy voting firms. Bayer is due to host its annual general meeting on April 28 but the company still faces potentially huge litigation risks stemming from […] Read more

Bayer reported inching toward glyphosate settlement

Reading Time: < 1 minute Reuters — Bayer has agreed on draft settlement terms with half a dozen law firms representing tens of thousands of plaintiffs alleging that its Roundup herbicide causes cancer, the Wall Street Journal reported on Friday, citing people familiar with the matter. Shares of the German drugs and pesticides company have come under immense pressure since […] Read more